Recurrence Prevention of Childhood Primary Angiitis of Central Nervous System by Combination of Azathioprine and Aspirin

Muhammad Akbar Malik^1, , Ghulam Rasul Choudry¹ and Hamza Malik²

¹Department of Paediatric Neurology, The Children’s Hospital, Lahore, Pakistan

²Department of Paediatric, Combined Military Hospital, Lahore, Pakistan

Cite this paper:
Muhammad Akbar Malik, Ghulam Rasul Choudry and Hamza Malik. Recurrence Prevention of Childhood Primary Angiitis of Central Nervous System by Combination of Azathioprine and Aspirin. American Journal of Medicine Studies. 2013; 1(3):22-27. doi: 10.12691/ajms-1-3-3

Abstract

The objectives of the study were to determine the frequency of various presenting features and its effect on final outcome in childhood primary angiitis of central nervous system (cPACNS). The study also aimed to determine the frequency of complications with use of anticoagulants followed by long term Aspirin and Azathioprine in patients with ischemic infarcts. The study was conducted at the department of the Neurosciences and the Neuroradiology of the Children's Hospital from 1st Jan 2009 to 31st December 2010. Over the period of 2 years, 68 patients with acute ischemic strokes were admitted, who presented within 14 days of onset of the symptoms. Patients with ischaemic infarcts were treated with anticoagulants at least for 04 weeks and this was followed by long term use of Aspirin and Azathioprine. Patient were followed in Hospital based cohort study at single center and were systemically assessed for clinical presentation, classification of cPACNS, adverse effects of anticoagulants, aspirin, azathioprine and their hospital course. Data were analyzed using the Statistical Package for the Social Sciences (SPSS) version 12.0 (Chicago, IL). 68 children with cAIS (boys 62%, girls 38%) with mean age of 8.5 years (median age 7.4 + 3.5 years), were enrolled in this study. Motor deficit (70%); headache (64%) and fever (20%) were the commonest symptoms, whereas, hemiparesis (60%); seizure 55 % (focal 35%, generalized 20%); and decreased conscious level (30%), were the commonest neurological findings. Neuroradiological findings of head revealed; ischemic strokes 50 (73.5%); hemorrhagic strokes 10 (14.7%) and ischaemic- haemorrhagic lesions 8(11.8%).Conventional angiography and/or MRA revealed that at the time of admission 51 (51/68, 75%) of the cohort had non-progressive (obliterative) and 17 (17/68,25%) had evidence of progressive arteriopathy. No secondary hemorrhagic was documented among infarcts strokes, which were treated with heparin and anticoagulants. Hospital outcome was as; survivors 56 (81.5%) and deaths 12 (18.5%). 40patints discharged on long term oral aspirin, and 14 children of these were commenced also on Azathioprine and are on follow-up. Male sex, deep conscious level and intra cerebral bleed causing severe raised intracranial pressure were the poor prognostic factor. The Neurological findings among 56 survivors were; normal 20%; minor disabilities 25%; moderate disabilities 20% and severe disabilities 35%.

Keywords:
primary angiitis intracerebral hemorrhage multiple aneurysms subarachnoid hemorrhage central nervous system children

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]	Lie JT. Primary (granulomatous) angiitis of the central nervous system: a clinicopathological analysis of 15 new cases and a review of the litratine. Hum Pathol 1992; 23:164-71.
[2]	Benseler SM, Silverman E, Aviv RI, et al. Primary central nervoussystem vasculitis in children. Arthritis Rheum 2006; 54: 1291-97.
[3]	Bensiler S, Schneider R. Central nervous system vasculitis in children. Curr Opin Rheumatol 2003;16:43-50.
[4]	Haff Ali A, R. Primary angiitis of the central nervous system differential diagnosis and treatment. Clinical Rhematoloty 2010; 24:413-28.
[5]	Hutchison C, Elibers I, Halliday W, Brasen H, Langtion S, Arnistrong D, Hawkins C, Westma Wtt R, Menseler M, S. Treatment of primary CNS vasculitis in children: an open label cohort study. The Lancet Neurology 2010; 9:1078-84.
[6]	Calabrese LH, Furlan AJ, Gragg LA, Ropos TJ. Primary angiitis of the central nervous system: diagnostic criteria and clinical approach. Cleve Clin J Med 1992; 59: 293-306.
[7]	Despina E,Tim C, Dawn S, Nigel J, Paul A. B, Vijey G. Investigation of childhood central nervous system vasculitis: magnetic resonance angiography versus catheter cerebral angiography. Developemental Medicine and Child Neurology 2010; 52:863-67.
[8]	Chung B, Wong V. Pediatric stroke among Hong Kong Chinese subjects. Pediatrics 2004; 114:206-12.
[9]	Salih MA, bdel-Gader AG, Al-Jarallah AA, Kentab AY, Alorainy IA, Hassan HH et al. Stroke in Saudi children: Epidemiology, clinical features and risk factors. Saudi Med J 2006; 27:12-20.
[10]	Strater R, Becker S, von Eckardstein, A, et al. Prospective assessment of risk factors for recurrent stroke during childhood:A 5 year follow-up study. Lancet 2002; 360:1540.
[11]	Soman T, Rafay F.M, Hune S, et al. The Risks and Safety of Clopidogrel in Pediatric Arterial Ischemic Stroke. Stroke 2006; 37:1120-22.
[12]	DeVeber G, Monagle P, Chan A, MacGregor D, Curtis R, Lee S et al. Prothrombotic disorders in infants and children with cerebral thromboembolism. Arch Neurol 1998; 55:1539-43.
[13]	Barnes C, Newall F, Furmedge J, MMackay M, Monagle P. Arterial ischaemic stroke in children. J Paediatr Child Health2004;40: 384-87.
[14]	Adams J.R, Donald J, Granger S.B, et al. Stroke and conversion to high risk in children screened with transcranial Doppler ultrasound. The STOP study 2004; 103: 3689-94.
[15]	Juin-Chang L; Kuang-Lin L;Huer-Shyong W, et al. Seizures in childhood ischaemic stroke in Taiwan.Brain and Development 2009; 31: 294-99.
[16]	16-Siddiqui TS, Rehman A, Ahmed B. Etiology of strokes and hemiplegia in children presenting at Ayub Teaching Hospital, Abbottabad. J Ayub Med Coll Abbottabad. 2006; 18:60-63.
[17]	Shi KL, Wang JJ, Li JW, Jiang LQ, Mix E, Fang F et al. Arterial ischemic stroke: experience in Chinese children. Pediatr Neurol 2008; 38:186-90.
[18]	Lanthier S, Carmant L, David M et al. Stroke in children: The coexistence of multiple risk factors predicts poor outcome Neurology 2000; 54:271-75.
[19]	Nagaraja D, Verma A, Taly AB, Kumar MV, Jayakumar PN. Cerebrovascular disease in children. Acta Neurol Scand. 1994; 90:251-55.
[20]	Braun J.P.K, Rafav F. M, Uiterwaal C.S.P. Anne-Marie P, DeVeber G. Mode of Onset Predicts Etiological Diagnosis of Arterial Ischemic Stroke in Children. Stroke 2007; 38:298-302.
[21]	Makihija Sonia, Aneja S, Tripathi.P.R and Narayan S. Etiolological Profile of Stroke and its Relation with pro-thrombotic states. Indian J Paediatr2008; 75:579-84.
[22]	Cnossen MH, Aarsen FK, Akker SLj, Danen R, Appel IM, Steyerberg EW, Catsman-Berrevoets CE.Paediatric arterial ischaemic stroke: functional outcome and risk factors. Dev Med Child Neurol 2010; 52:394-9.
[23]	Stephen D, Weigand, MS,3 Dylan V. Miller, MD,4 Caterina Giannini, MD,4 James F. Meschia, MD,5 John Huston III, MD,6 and Gene G. Hunder, MD7Neurocrit Care (2010) 12:132-143.
[24]	Dennis N. Bourdette, Anish Bhardwaj. Immunomodulatory Therapies in Neurologic Critical Care. Neurocrit Care 2010;12:132-43.
[25]	Hankey GJ. Secondary prevention of recurrent stroke. Stroke 2005; 36:218-21.